Groupe Berkem announces the acquisition of U.S. distributor i.Bioceuticals

In France, biobased chemicals firm Groupe Berkem announced the closing of the acquisition of i.Bioceuticals, a North American distributor of nutritional ingredients from INC. Olivier Fahy, Chairman and CEO of Groupe Berkem, said: “Thanks to its know-how in plant extraction and more specifically in the antioxidant market targeting health purposes, Groupe Berkem has been able to design bio-based solutions covering a wide range of business segments, particularly in the Health, Beauty & Nutrition market. It is in this fast-growing market that we wanted to make this acquisition, which will enable us to directly address the very promising food supplements segment in the dynamic North American market.” The acquisition of this subsidiary, located in the state of Massachusetts in the United States, enables Groupe Berkem to distribute directly in North America one of its full range of antioxidant active ingredients. This presence will enable the firm to consolidate links with its already well-established client base in the other targeted sectors of bio-based chemistry, Groupe Berkem said.

More on the story.